Get the Stockscreener App
6.04
12.27%
0.66
After Hours:
6.41
0.37
+6.13%
Eupraxia Pharmaceuticals Inc stock is traded at $6.04, with a volume of 184.23K.
It is up +12.27% in the last 24 hours and up +13.96% over the past month.
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
See More
Previous Close:
$5.38
Open:
$5.47
24h Volume:
184.23K
Relative Volume:
13.27
Market Cap:
$217.20M
Revenue:
-
Net Income/Loss:
$-25.50M
P/E Ratio:
-7.8442
EPS:
-0.77
Net Cash Flow:
$-30.10M
1W Performance:
+10.42%
1M Performance:
+13.96%
6M Performance:
+45.89%
1Y Performance:
+118.84%
1-Day Range:
$5.41
$6.31
1-Week Range:
$5.22
$6.31
52-Week Range:
$2.20
$6.31
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Name
Eupraxia Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare EPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
6.04 | 193.46M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-24-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-25 | Initiated | H.C. Wainwright | Buy |
| Jun-16-25 | Initiated | Canaccord Genuity | Speculative Buy |
| Feb-21-25 | Initiated | Craig Hallum | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Latest News
Is it time to cut losses on Eupraxia Pharmaceuticals Inc.July 2025 Technicals & Real-Time Volume Triggers - newser.com
Is now a turning point for Eupraxia Pharmaceuticals Inc.Quarterly Trade Report & Technical Entry and Exit Tips - newser.com
Using data models to predict Eupraxia Pharmaceuticals Inc. stock movementWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Using economic indicators to assess Eupraxia Pharmaceuticals Inc. potential2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Quantitative breakdown of Eupraxia Pharmaceuticals Inc. recent moveBreakout Watch & High Accuracy Swing Trade Signals - newser.com
Has Eupraxia Pharmaceuticals Inc. found a price floorJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
What’s next for Eupraxia Pharmaceuticals Inc. stock priceJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
Rate Cut: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEARTrade Entry Report & Low Risk Investment Opportunities - خودرو بانک
CEO Change: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingJuly 2025 Action & Fast Entry High Yield Tips - خودرو بانک
Street Watch: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Trend Summary & Verified Swing Trading Watchlists - خودرو بانک
Aug Momentum: What is the dividend yield of Eupraxia Pharmaceuticals IncQuarterly Investment Review & High Conviction Trade Alerts - خودرو بانک
Historical volatility pattern of Eupraxia Pharmaceuticals Inc. visualizedTrend Reversal & Accurate Intraday Trade Tips - newser.com
Aug Closing: Whats the beta of Eupraxia Pharmaceuticals Inc stock2025 Price Momentum & Daily Profit Maximizing Tips - خودرو بانک
Analyzing Eupraxia Pharmaceuticals Inc. with multi timeframe chartsQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Growth Report: Whats the outlook for Eupraxia Pharmaceuticals Incs sector2025 Support & Resistance & Technical Pattern Based Signals - خودرو بانک
Has Eupraxia Pharmaceuticals Inc. formed a bullish divergencePortfolio Value Report & Low Drawdown Momentum Ideas - newser.com
Valuation Update: Is Eupraxia Pharmaceuticals Inc affected by consumer sentimentWeekly Risk Report & Verified Short-Term Trading Plans - خودرو بانک
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Trading Down 0%Here's What Happened - MarketBeat
Brokerages Set Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) PT at $11.00 - Defense World
Measuring Eupraxia Pharmaceuticals Inc.’s beta against major indicesPortfolio Value Summary & Stepwise Swing Trade Plans - newser.com
What the charts say about Eupraxia Pharmaceuticals Inc. today2025 Historical Comparison & AI Based Buy and Sell Signals - newser.com
What to expect from Eupraxia Pharmaceuticals Inc. in the next 30 daysMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Is Eupraxia Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Can volume confirm reversal in Eupraxia Pharmaceuticals Inc.2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser
What momentum shifts mean for Eupraxia Pharmaceuticals Inc.Weekly Risk Summary & Free Real-Time Market Sentiment Alerts - Newser
Understanding Eupraxia Pharmaceuticals Inc.’s price movementJuly 2025 PreEarnings & Fast Gaining Stock Reports - Newser
Eupraxia Pharmaceuticals : Reports Second Quarter 2025 Financial Results and Provides Business Update - MarketScreener
Can swing trading help recover from Eupraxia Pharmaceuticals Inc. losses2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Applying sector rotation models to Eupraxia Pharmaceuticals Inc.Market Weekly Review & Safe Capital Growth Tips - Newser
Is Eupraxia Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Levels & Reliable Entry Point Alerts - Newser
How to interpret RSI for Eupraxia Pharmaceuticals Inc. stockJuly 2025 Review & Weekly Breakout Watchlists - Newser
Eupraxia Pharmaceuticals Inc Stock (EPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):